China's FDA urged to get track-and-trace system in place

Chinese drug companies are urging the country's Food and Drug Administration to act quickly to replace a supplier for a track-and-trace system there. The FDA recently put its project on hold after companies complained that its contract with a unit of Alibaba Group ($BABA) to design the barcode tracking system gave the Hong Kong-based company an unfair edge as it moves to fulfill its online drug selling ambitions. "I advise the CFDA to introduce a new tracking system with more detailed columns … and please be as quick as possible," Wei Feiyan, board chairwoman of Guangxi-based Huahong Pharmaceutical and a deputy to National People's Congress, said at an annual legislative meeting of Chinese leadership where health policy was discussed. More from FiercePharmaAsia

Suggested Articles

The antidepressant Zoloft and its generics are in short supply as the COVID-19 pandemic has caused higher demand and manufacturing interruptions.

WuXi AppTec has appointed Celgene CAR-T program veteran David Chang to lead its cell and gene therapy CDMO, WuXi Advanced Therapies.

Maryland-based Emergent BioSolutions has won a $628 million contract with BARDA to manufacture targeted COVID-19 vaccine hopefuls.